Guidelines: ESMO Guidelines Compilation (European Union): Difference between revisions
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
'''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]] [https://www.esmo.org/guidelines/guidelines-by-topic]. | '''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]] [https://www.esmo.org/guidelines/guidelines-by-topic]. | ||
'''Access to information:''' | '''Access to information:''' [[dataAvailability::publicly available]] [https://www.esmo.org/guidelines/guidelines-by-topic]. | ||
Revision as of 12:29, 26 April 2024
Go back to European Union page
Primary purpose: Give providers recommendations prepared and reviewed by leading experts in each topic to help patients with the best care available.
Sponsor, manager or home institution: European Society for Medical Oncology.
Available guidelines: Available Guidelines: ESMO Guidelines [1].
Type of information: Guidelines for each step in the cancer journey including information on cancer incidence and epidemiology; diagnosis, pathology and molecular biology; staging and risk assessment; management of advanced and metastatic disease; personoalised medicine; long-term implications and survivorship; among other information specific to each cancer type. All guidelines have references and methodology sections [2].
Cancer Areas of Interest: C00-C97: All cancer types [3].
Access to information: publicly available [4].
